Hosted on MSN8d
Regeneron’s macular oedema therapy shows promise in Phase III trial
In the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Rolling Stone26d
Central Cee Shows That Patience Is a Virtue on ‘Can’t Rush Greatness’
Enter Central Cee, the 25-year-old rap sensation from the West London neighborhood of Shepherd’s Bush, whose reign over social feeds these past few years feels uncontested. With his studio debut ...
Medscape27d
Review of Anti-vascular Endothelial Growth Factor Therapy in Macular Edema Secondary to Central Retinal Vein Occlusions
Table 1. Summary of evidence: results of anti-vascular endothelial growth factor treatment on central retinal vein occlusion macular edema. n = 2 in second-year BRVO n = 3.5 in second-year CRVO ...
Medscape28d
Review of Anti-vascular Endothelial Growth Factor Therapy in Macular Edema Secondary to Central Retinal Vein Occlusions
The dilemma still holds regarding treatment of the very ischemic central retinal vein occlusion subgroup with ME with profound visual loss. Combination therapy of anti-VEGF agents and a steroid ...
Medical Xpress29d
Ziapin2 effectively restores retinal function in preclinical models of retinitis pigmentosa and macular degeneration
"We have been able to demonstrate that Ziapin2 can regenerate the physiological antagonism between the ON retinal neurons, which signal the presence of light, and the OFF neurons, which signal the ...